NCT00112476View on ClinicalTrials.gov

Temsirolimus and Bryostatin 1 in Treating Patients With Unresectable or Metastatic Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

July 31, 2010

Conditions
Recurrent MelanomaRecurrent Renal Cell CancerStage IV MelanomaStage IV Renal Cell CancerUnspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

bryostatin 1

Given IV

DRUG

temsirolimus

Given IV

Trial Locations (1)

19111-2497

Fox Chase Cancer Center, Philadelphia

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00112476 - Temsirolimus and Bryostatin 1 in Treating Patients With Unresectable or Metastatic Solid Tumors | Biotech Hunter | Biotech Hunter